Having discussed the use of ARBs, CCBs and diuretics in hypertension, is it time to shift towards triple therapy? Professor Bernard Waeber explores the heterogeneity of patients with hypertension and provides his insights into the use of triple therapy.
The use of triple therapy in hypertension: a rational next step from dual therapy. Why is combination therapy necessary? Professor Waeber reviews the current guideline recommendations and outlines the heterogeneity seen in patients with hypertension that makes management so difficult.
The use of triple therapy in hypertension: a rational next step from dual therapy. In this second part, Professor Waeber explores theory with reality and looks at the efficacy and tolerability of triple combination therapy in patients with hypertension.